Log in | Register

Top ten tips for the management of critically ill hematopoietic stem cell transplantation recipients

Etienne Lengliné| Adrien Mirouse| Elie Azoulay
What's New in Intensive Care
Online First ™ - March , 2019

Pages 1 - 4

No abstract available.

References

  1. Kerhuel L, Amorim S, Azoulay E, Thiéblemont C, Canet E (2015) Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Leuk Lymphoma 56:3090–3095
    • View reference on publisher's website
  2. Jantunen E et al (2006) Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76:245–250
    • View reference on publisher's website
  3. Bayraktar UD et al (2013) Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 31:4207–4214
    • View reference on publisher's website
  4. Canet E et al (2014) Acute kidney injury in critically ill allo-HSCT recipients. Bone Marrow Transplant 49:1121
    • View reference on publisher's website
  5. Lengliné E et al (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840–845
    • View reference on publisher's website
  6. Saillard C, Blaise D, Mokart D (2016) Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51:1050–1061
    • View reference on publisher's website
  7. Azoulay E et al (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359–367
    • View reference on publisher's website
  8. Soares M et al (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34:3315–3324
    • View reference on publisher's website
  9. Gooley TA et al (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101
    • View reference on publisher's website
  10. Mokart D et al (2015) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 30:1107–1113
    • View reference on publisher's website
  11. Azoulay E et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818
    • View reference on publisher's website
  12. Contejean A et al (2016) Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care 6:102
    • View reference on publisher's website
  13. Schnell D et al (2013) Clinical assessment for identifying causes of acute respiratory failure in cancer patients. Eur Respir J 42:435–443
    • View reference on publisher's website
  14. Kontoyiannis DP et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100
    • View reference on publisher's website
  15. Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366
    • View reference on publisher's website
  16. Lueck C et al (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483–1492
  17. Nakamura M et al (2018) Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol 108:622–629
    • View reference on publisher's website
  18. Azoulay E et al (2019) Critical care management of chimeric antigen receptor-T cells-related toxicity: be aware and prepared. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.201810-1945ED

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement